Breaking News

Reliable Biopharma Expands Manufacturing Capacity

February 22, 2016

Increases output of lithium dodecyl sulfate and sodium dodecyl dulfate in its St. Louis facility

Reliable Biopharmaceutical has expanded their manufacturing capacity for lithium dodecyl sulfate (LDS) and sodium dodecyl sulfate (SDS). Both products are manufactured at the company’s St. Louis, MO facility and are used in the manufacture of diagnostic tests and in the pharmaceutical industry for protein isolation and purification.

“Reliable continues to leverage our quality systems and proprietary purification technology to produce the highest quality excipients in the world,” said David Feldker president and chief executive officer, Reliable. “We are committed to our customer’s success and their requirement for high purity ingredients.”

Related Contract Manufacturing:

  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks